Predictors of SARS-CoV-2 Infection in University Students: A Case-Control Study.

SARS-CoV-2 case-control study high education institution risk factors students

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
03 11 2022
Historique:
received: 28 08 2022
revised: 30 10 2022
accepted: 30 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Closure of Higher Education Institutions in the early phase of the SARS-CoV-2 pandemic was largely diffused. With their reopening, numerous preventive measures have been enacted, but limited evidence exists on students' behavior that could influence their infection risk. We conducted a case-control study at the Sapienza University of Rome to identify protective and risk factors for SARS-CoV-2 infection. Students attending the campus within 48 h of SARS-CoV-2 infection were considered cases. Controls were students who come in contact with a confirmed case within the campus. Demographic features and activities carried out before positivity or contact were investigated. Multivariable logistic regression models were built to identify factors associated with SARS-CoV-2 infection, estimating adjusted odds ratios (aOR) and 95% confidence intervals (95% CI). The analysis showed an increased risk of SARS-CoV-2 infection for attending the second year or above of university (aOR 17.7, 95% CI 2.21-142.82) and participating in private parties or ceremonies (aOR 15.9, 95% CI 2.30-109.67) while living outside the family (aOR 0.08, 95% CI 0.01-0.54) and attending practical activities or libraries on campus (aOR 0.29, 95% CI 0.08-0.97) reduced the risk. Data strongly suggests that it may be safe to participate in activities organized under strict infection prevention guidelines. Tailored prevention measures might reduce the risk of infection in university students.

Identifiants

pubmed: 36361257
pii: ijerph192114376
doi: 10.3390/ijerph192114376
pmc: PMC9655450
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2021 Jun 4;372(6546):1092-1097
pubmed: 33927057
BMC Public Health. 2022 Aug 2;22(1):1470
pubmed: 35915479
Science. 2022 May 6;376(6593):eabn4947
pubmed: 35289632
BMJ. 2021 Mar 18;372:n628
pubmed: 33737413
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1404-1409
pubmed: 33001872
JAMA. 2020 Nov 3;324(17):1727-1728
pubmed: 32991681
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Int J Environ Res Public Health. 2021 Feb 16;18(4):
pubmed: 33669412
Influenza Other Respir Viruses. 2022 Sep;16(5):952-961
pubmed: 35470969
Lancet Respir Med. 2021 Dec;9(12):1450-1466
pubmed: 34688434
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1743-1747
pubmed: 33211678
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1416-1418
pubmed: 33001871
Front Public Health. 2021 Nov 04;9:772782
pubmed: 34805081
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1258-1264
pubmed: 32915165
Clin Infect Dis. 2020 Nov 5;71(8):1943-1946
pubmed: 32301964
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
Clin Infect Dis. 2021 Aug 2;73(3):e754-e764
pubmed: 33560412
J Gen Intern Med. 2021 Mar;36(3):753-761
pubmed: 33403622
J Epidemiol Community Health. 2022 Jul 11;:
pubmed: 35817467
Elife. 2021 Nov 25;10:
pubmed: 34821551
JAMA Netw Open. 2022 Apr 1;5(4):e229317
pubmed: 35482308
Vaccines (Basel). 2021 Nov 07;9(11):
pubmed: 34835223
Eur Geriatr Med. 2020 Oct;11(5):829-841
pubmed: 32671732
Sci Rep. 2022 Feb 28;12(1):3313
pubmed: 35228585
Int J Epidemiol. 2012 Oct;41(5):1480-9
pubmed: 23045208
J Clin Med. 2021 Jul 21;10(15):
pubmed: 34361998
JAMA Intern Med. 2021 Aug 1;181(8):1090-1099
pubmed: 34152363
Allergy. 2021 Feb;76(2):428-455
pubmed: 33185910
Cell Rep Med. 2022 Feb 21;3(3):100556
pubmed: 35474742
Lancet Reg Health Eur. 2022 Feb;13:100278
pubmed: 34849500
Lancet Reg Health Eur. 2021 Aug;7:100148
pubmed: 34124709
Arch Dis Child. 2021 Feb;106(2):111-113
pubmed: 32747375
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):118-122
pubmed: 33507894
J Adolesc Health. 2020 Dec;67(6):763-768
pubmed: 33071164
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):830-835
pubmed: 32614814
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):751-758
pubmed: 32555138
Int J Environ Res Public Health. 2021 May 28;18(11):
pubmed: 34071535
Epidemiol Infect. 2022 May 10;150:e115
pubmed: 35535456
Int J Environ Res Public Health. 2022 Jun 27;19(13):
pubmed: 35805539
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1925-1929
pubmed: 33332298
MMWR Morb Mortal Wkly Rep. 2021 Sep 03;70(35):1201-1205
pubmed: 34473686

Auteurs

Giuseppe Migliara (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Erika Renzi (E)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Valentina Baccolini (V)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Ambrogio Cerri (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Pierluigi Donia (P)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Azzurra Massimi (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Carolina Marzuillo (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Corrado De Vito (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Leandro Casini (L)

Special Office for Prevention, Protection and High Vigilance, Sapienza University of Rome, 00185 Rome, Italy.

Antonella Polimeni (A)

Department of Oral and Maxillofacial Science, Sapienza University of Rome, 00185 Rome, Italy.

Eugenio Gaudio (E)

Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, 00185 Rome, Italy.

Paolo Villari (P)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH